glp-1 agonists for type 2 diabetes GLP1 Receptor vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog Schematic illustration of monoagonists, dual
Description
Future research also could explore the effects of individual GLP-1 agents rather than the drug class as a whole
Charlotte, NC: American College of Gastroenterology
These investigations found regulatory networks for intestinal microbiota imbalance, HBV infection, miR-1925p, and GLP-1 expression [173]
GIP has also been shown to have actions beyond its effect on insulin secretion (Fig
Plus, rapid weight loss associated with GLP-1s may contribute to gallstone formation, while the emotional and psychological impacts of sudden changes in appetite and body composition remain unstudied
